News
R1 RCM (NASDAQ:RCM) ticked higher after the European antitrust regulator approved Towerbrook and CD&R's planned $14.30 a share purchase. The European Commission approved the combination under a ...
R1 RCM (NASDAQ:RCM) agreed to be sold to TowerBrook and Clayton, Dubilier & Rice in a deal valued at $8.9 billion. R1 RCM ...
As DeepSeek usage spread rapidly among researchers and enterprises, Meta was reportedly sent into panic mode upon learning that this new R1 model had been trained for a fraction of the cost of ...
AI RCM Vendor Names by Respondents: Waystar, Optum360, R1 RCM Startup Vendors to Watch: qBotica, Alpha Health, TailorMed Survey Insight: Ranked top innovation by 78%; 85% reported improved upfront ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results